News
Walgreens to pay $300M to settle with Department of Justice over opioid allegations
Walgreens Boots Alliance has agreed to pay $300 million to settle allegations that it filled millions of invalid prescriptions for opioids and other controlled substances and illegally billed federal programs such as Medicare for those medications, the U.S. Department of Justice announced Monday.
Recently, Walgreens Boots Alliance struck a deal with private ... retailers who closed up shop after being bought by private-equity firms”. At the very least, “the fundamental problems ...
NEW YORK — Walgreens Boots Alliance says it has agreed to be acquired by the private equity firm Sycamore Partners as the struggling retailer looks to turn itself around after years of ...
“A few weeks ago, Walgreens decided to sell out to a private equity firm, a storied name ... in retail drugstore operator, Walgreens Boots Alliance, Inc. (NASDAQ:WBA) following the wash ...
Walgreens Boots Alliance (NASDAQ: WBA) is in a pending acquisition with Sycamore Partners, a private equity firm, to take the ...
Walgreens reports Q2 revenue beat with strong pharmacy growth, but earnings fall amid weaker retail sales and U.S. Healthcare shifts.
Walgreens delivered a better-than-expected fiscal second quarter and a smaller loss a month after announcing that it would be bought by a private equity ... Walgreens Boots Alliance Inc.
On March 6, Walgreens Boots Alliance entered an agreement to be acquired by private equity firm Sycamore Partners. With the recent buzz around Walgreens, some investors may also be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback